PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Income
$29.35M
TTM · Period ending: · USD
PHAS Operating Income
Latest reported$29.35Mperiod ending
Latest reported$29.35Mperiod ending
PHAS Operating Income (-$9.50M → $29.35M)
Annual operating income
High-resolution chart · PNG
PHAS operating income history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Income (USD) |
|---|---|
| -130,418 | |
| -84,856,000 | |
| -39,736,000 | |
| -19,644,000 | |
| -8,538,000 | |
| -9,501,000 |